nCoV Map

Higher risk of rehospitalisation and death following COVID-19 hospitalisation
28 January, 2022
People hospitalised due to COVID-19 are at a higher risk of rehospitalisation and death compared to general population
COVID-19
COVID-19 vaccine update - Different vaccine brand as booster dose
Nepal // 28 January, 2022
Brand other than vero cell can be used as booster
COVID-19
Third doses protect against hospitalisation
United States // 27 January, 2022
CDC study examines benefits of mRNA vaccine…
COVID-19
European Medicines Agency recommends conditional approval for Paxlovid
27 January, 2022
EMA recommends conditional approval for Paxlovid...
COVID-19
ECDC Assessment of the further emergence and potential impact of the SARS-CoV-2 Omicron variant of concern in the EU/EEA, 19th update
27 January, 2022
ECDC 19th update on SARS-CoV-2 and focus on Omicron VOC...
COVID-19
Moderna begins trials for Omicron-specific booster shot
27 January, 2022
Moderna announced that it has begun phase two trials of a booster dose of its vaccine designed to target the Omicron variant...
COVID-19
All COVID-19 restrictions to end on 31 January
Denmark // 26 January, 2022
COVID-19 no longer classified as “socially critical disease”…
COVID-19
WHO COVID-19 Weekly Reports, January 2022
25 January, 2022
Summary of WHO weekly reports...
COVID-19
Pfizer and BioNTech commence trial of Omicron specific vaccine
25 January, 2022
Pfizer and BioNTech commence variant specific vaccine trial...
COVID-19
USA Food and Drug Administration revises authorisations for certain COVID-19 treatments
United States // 25 January, 2022
US FDA revises monocolonal antibody treatment authorisation...
COVID-19
Vaccine update - Five year olds eligible for Pfizer
Egypt // 25 January, 2022
Pfizer vaccine is eligible for five-year-olds
COVID-19
COVID-19 Updates, January 2022 - FDA limits use of some treatment options
United States // 25 January, 2022
Omicron now dominant, limited use of some treatment options...
COVID-19
Omicron cases doubling in European Region
24 January, 2022
Statement from WHO Regional Director for Europe…
COVID-19
Novavax approved for emergency use
Belgium // 24 January, 2022
First doses to arrive in February…
COVID-19
WHO Director General opens the 150th session of the Executive Board
24 January, 2022
150th session of WHO Executive Board opening remarks...
COVID-19
Study: Increased antibodies with differing booster vaccines after Sinovac primary schedule
24 January, 2022
Booster with different vaccine after Sinovac/CoronaVac is more effective...
COVID-19
Study: COVID-19 may infect the inner ear causing symptoms
24 January, 2022
COVID-19 may infect the inner ear leading to pain, hearing loss, tinnitus...
COVID-19
Vaccination for children and fourth booster shots planned
Thailand // 24 January, 2022
Vaccintion for children between 5 and 11 years; fourth vaccine dose for residents in...
COVID-19
Omicron sub-lineage BA.2 as variant under investigation (VUI)
United Kingdom // 22 January, 2022
UK Health Security Agency (UKHSA) has stated...
COVID-19
Strong antibody response among those infected with COVID-19 post-vaccination, study
United States // 22 January, 2022
The more exposure to SARS-CoV-2 antigens, the more enhanced the quality of antibody responses...
COVID-19

Quick Links

nCoV Map

LATEST NEWS (PREMIUM ACCESS)